Investing Profile

Elena Viboch

InvestorVC
Partner at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Partner at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (August Capital).

cb
$500K - $2.0M
$500K
11
$1.1B
CompanyStageDateRound SizeTotal Raised
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Magaly Charbonneau (iNovia Capital), Sara Thomas Deshpande (Maven Ventures)
CTRL Therapeutics
SeedApr 2023$10M
$10M
Faro Health
Series AFeb 2023$20M
$35M
Co-investors: Andy Harrison (Section 32)
Paradigm
Series AJan 2023$200M
$250M
Co-investors: Niko Bonatsos (General Catalyst), Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Alaa Halawa (Mubadala), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Scott Belsky, Balaji Srinivasan, Arash Ferdowsi, Eoghan McCabe
ArriVent Biopharma
Series BDec 2022$160M
$160M
Co-investors: Carl Gordon (OrbiMed), James Healy (Sofinnova Investments)
Vial
Series BNov 2022$67M
$100M
Co-investors: Adam Rothenberg (BoxGroup), David Tisch (BoxGroup), Jeffrey Silverstein (Andreessen Horowitz), Josh Buckley (Buckley Ventures), Hemant Taneja (General Catalyst), Greg Rosen (BoxGroup), Nimi Katragadda (BoxGroup), Blake Byers (Byers Capital), TJ Nahigian (Base10 (Base10 Partners) ), Gordon Wintrob, Zak Kukoff, Nikhil Krishnan
Odyssey Therapeutics
Series BOct 2022$170M
$490M
Co-investors: Carl Gordon (OrbiMed), Jill carroll (SR One), Lorence Kim (Third Rock Ventures)